• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑质神经黑色素磁共振成像在不同亚型帕金森病患者中的应用。

Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease.

机构信息

Department of Neurology, China-Japan Union Hospital of Jilin University, Xiantai street 126, Changchun, 130033, Jilin Province, China.

出版信息

J Neural Transm (Vienna). 2021 Feb;128(2):171-179. doi: 10.1007/s00702-020-02295-8. Epub 2021 Feb 9.

DOI:10.1007/s00702-020-02295-8
PMID:33559725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7914244/
Abstract

Neuromelanin (NM) is a dark pigment that mainly exists in neurons of the substantia nigra pars compacta (SNc). In Parkinson disease (PD) patients, NM concentration decreases gradually with degeneration and necrosis of dopamine neurons, suggesting potential use as a PD biomarker. We aimed to evaluate associations between NM concentration in in vivo SN and PD progression and different motor subtypes using NM magnetic resonance imaging (NM-MRI). Fifty-four patients with idiopathic PD were enrolled. Patients were divided into groups by subtypes with different clinical symptoms: tremor dominant (TD) group and postural instability and gait difficulty (PIGD) group. Fifteen healthy age-matched volunteers were enrolled as controls. All subjects underwent clinical assessment and NM-MRI examination. PD patients showed significantly decreased contrast-to-noise ratio (CNR) values in medial and lateral SN (P < 0.05) compared to controls. CNR values in lateral SN region decreased linearly with PD progression (P = 0.001). PIGD patients showed significant decreases in CNR mean values in lateral SN compared to TD patients (P = 0.004). Diagnostic accuracy of using lateral substantia nigra (SN) in TD and PIGD groups was 79% (sensitivity 76.5%, specificity 78.6%). NM concentration in PD patients decreases gradually during disease progression and differs significantly between PD subtypes. NM may be a reliable biomarker for PD severity and subtype identification.

摘要

神经黑色素(NM)是一种深褐色的色素,主要存在于致密部黑质神经元中。在帕金森病(PD)患者中,随着多巴胺神经元的变性和坏死,NM 浓度逐渐降低,提示其可能作为 PD 的生物标志物。本研究旨在使用 NM 磁共振成像(NM-MRI)评估体内 SN 中 NM 浓度与 PD 进展和不同运动亚型之间的关系。纳入 54 例特发性 PD 患者。根据不同的临床症状将患者分为震颤为主型(TD)组和姿势不稳及步态困难型(PIGD)组。纳入 15 名年龄匹配的健康志愿者作为对照组。所有受试者均接受临床评估和 NM-MRI 检查。与对照组相比,PD 患者的中脑 SN 内侧和外侧的对比噪声比(CNR)值显著降低(P<0.05)。外侧 SN 区域的 CNR 值随 PD 进展呈线性下降(P=0.001)。与 TD 患者相比,PIGD 患者的外侧 SN 中 CNR 平均值显著降低(P=0.004)。TD 和 PIGD 组中使用外侧 SN 的诊断准确率为 79%(灵敏度 76.5%,特异性 78.6%)。PD 患者的 NM 浓度在疾病进展过程中逐渐降低,且在不同的 PD 亚型之间存在显著差异。NM 可能是 PD 严重程度和亚型识别的可靠生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/c2fed3505dc0/702_2020_2295_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/3e7ccce3c97a/702_2020_2295_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/30516a4382a6/702_2020_2295_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/e86b22ed1c06/702_2020_2295_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/c2fed3505dc0/702_2020_2295_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/3e7ccce3c97a/702_2020_2295_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/30516a4382a6/702_2020_2295_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/e86b22ed1c06/702_2020_2295_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a03/7914244/c2fed3505dc0/702_2020_2295_Fig4_HTML.jpg

相似文献

1
Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease.黑质神经黑色素磁共振成像在不同亚型帕金森病患者中的应用。
J Neural Transm (Vienna). 2021 Feb;128(2):171-179. doi: 10.1007/s00702-020-02295-8. Epub 2021 Feb 9.
2
Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.使用神经黑色素敏感磁共振成像评估帕金森病运动功能障碍的亚型
Neurosci Lett. 2017 Jan 18;638:145-150. doi: 10.1016/j.neulet.2016.12.036. Epub 2016 Dec 16.
3
Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.原发性帕金森病及其表型的黑质和蓝斑神经黑色素敏感磁共振成像特征。
Eur J Neurol. 2018 Jul;25(7):949-e73. doi: 10.1111/ene.13628. Epub 2018 Apr 11.
4
Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease.黑质神经黑色素敏感 MRI:一种用于区分特发性震颤与震颤为主型帕金森病的影像学生物标志物。
Parkinsonism Relat Disord. 2019 Jan;58:3-8. doi: 10.1016/j.parkreldis.2018.07.007. Epub 2018 Jul 17.
5
Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.蓝斑和黑质病变与帕金森病患者认知和运动功能的关系。
Neurology. 2021 Sep 7;97(10):e1007-e1016. doi: 10.1212/WNL.0000000000012444. Epub 2021 Jun 29.
6
An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.应用神经黑色素敏感 MRI 研究帕金森病患者黑质和蓝斑内神经黑色素的分布。
BMC Neurol. 2023 Aug 14;23(1):301. doi: 10.1186/s12883-023-03350-z.
7
Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.黑质神经黑色素作为帕金森病疾病进展的影像学生物标志物
J Parkinsons Dis. 2017;7(3):491-501. doi: 10.3233/JPD-171135.
8
Regional nigral neuromelanin degeneration in asymptomatic leucine-rich repeat kinase 2 gene carrier using MRI.使用 MRI 检测无症状的富亮氨酸重复激酶 2 基因携带者的黑质区域神经黑色素变性。
Sci Rep. 2024 May 9;14(1):10621. doi: 10.1038/s41598-024-59074-8.
9
Neuromelanin-Sensitive Magnetic Resonance Imaging as a Measure for Differential Diagnosis of Essential Tremor and Parkinson's Disease.神经黑色素敏感磁共振成像作为鉴别特发性震颤和帕金森病的一种手段。
Neurol India. 2023 Jul-Aug;71(4):716-724. doi: 10.4103/0028-3886.383826.
10
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.帕金森病中黑质色素MRI信号的纵向变化:一种疾病进展标志物
Mov Disord. 2021 Jul;36(7):1592-1602. doi: 10.1002/mds.28531. Epub 2021 Mar 10.

引用本文的文献

1
Early Changes in the Locus Coeruleus in Mild Cognitive Impairment with Lewy Bodies.路易体轻度认知障碍中蓝斑核的早期变化。
Mov Disord. 2025 Feb;40(2):276-284. doi: 10.1002/mds.30058. Epub 2024 Nov 13.
2
Machine learning approaches for biomolecular, biophysical, and biomaterials research.用于生物分子、生物物理和生物材料研究的机器学习方法。
Biophys Rev (Melville). 2022 Jun 3;3(2):021306. doi: 10.1063/5.0082179. eCollection 2022 Jun.
3
Comparison of automated and manual quantification methods for neuromelanin-sensitive MRI in Parkinson's disease.

本文引用的文献

1
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.神经黑色素敏感 MRI 作为一种非侵入性的人类大脑多巴胺功能替代测量指标。
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5108-5117. doi: 10.1073/pnas.1807983116. Epub 2019 Feb 22.
2
Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI.利用神经黑色素敏感 MRI 检测黑质的寿命期色素变化。
Mov Disord. 2018 Nov;33(11):1792-1799. doi: 10.1002/mds.27502. Epub 2018 Nov 13.
3
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.
帕金森病中神经黑色素敏感 MRI 的自动与手动定量方法比较。
Hum Brain Mapp. 2024 Jan;45(1):e26544. doi: 10.1002/hbm.26544. Epub 2023 Dec 2.
4
An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.应用神经黑色素敏感 MRI 研究帕金森病患者黑质和蓝斑内神经黑色素的分布。
BMC Neurol. 2023 Aug 14;23(1):301. doi: 10.1186/s12883-023-03350-z.
5
Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.蓝斑核的神经黑色素相关超高场信号强度在帕金森病患者和对照组之间存在差异。
Neuroimage Clin. 2023;39:103479. doi: 10.1016/j.nicl.2023.103479. Epub 2023 Jul 22.
6
Application of Neuromelanin MR Imaging in Parkinson Disease.神经黑色素磁共振成像在帕金森病中的应用。
J Magn Reson Imaging. 2023 Feb;57(2):337-352. doi: 10.1002/jmri.28414. Epub 2022 Aug 26.
7
Nigral neuropathology of Parkinson's motor subtypes coincide with circuitopathies: a scoping review.帕金森运动亚型的黑质神经病理学与环路病变一致:范围综述。
Brain Struct Funct. 2022 Sep;227(7):2231-2242. doi: 10.1007/s00429-022-02531-9. Epub 2022 Jul 19.
8
Current Perspectives on the Assessment and Management of Gait Disorders in Parkinson's Disease.帕金森病步态障碍评估与管理的当前观点
Neuropsychiatr Dis Treat. 2021 Sep 21;17:2965-2985. doi: 10.2147/NDT.S304567. eCollection 2021.
神经黑色素细胞器是一种特殊的自噬溶酶体,在衰老的人类大脑中积累未降解的蛋白质和脂质,可能与帕金森病有关。
NPJ Parkinsons Dis. 2018 Jun 5;4:17. doi: 10.1038/s41531-018-0050-8. eCollection 2018.
4
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.通过磁共振成像(MRI)检测神经黑色素及其作为帕金森病生物标志物的前景。
NPJ Parkinsons Dis. 2018 Apr 10;4:11. doi: 10.1038/s41531-018-0047-3. eCollection 2018.
5
Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.原发性帕金森病及其表型的黑质和蓝斑神经黑色素敏感磁共振成像特征。
Eur J Neurol. 2018 Jul;25(7):949-e73. doi: 10.1111/ene.13628. Epub 2018 Apr 11.
6
Comparison of clinical features among Parkinson's disease subtypes: A large retrospective study in a single center.帕金森病亚型的临床特征比较:单中心大回顾性研究。
J Neurol Sci. 2018 Mar 15;386:39-45. doi: 10.1016/j.jns.2018.01.013. Epub 2018 Jan 11.
7
Motor subtype changes in early Parkinson's disease.早期帕金森病的运动亚型变化。
Parkinsonism Relat Disord. 2017 Oct;43:67-72. doi: 10.1016/j.parkreldis.2017.07.018. Epub 2017 Jul 21.
8
Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.黑质神经黑色素作为帕金森病疾病进展的影像学生物标志物
J Parkinsons Dis. 2017;7(3):491-501. doi: 10.3233/JPD-171135.
9
Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.使用神经黑色素敏感磁共振成像评估帕金森病运动功能障碍的亚型
Neurosci Lett. 2017 Jan 18;638:145-150. doi: 10.1016/j.neulet.2016.12.036. Epub 2016 Dec 16.
10
In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies.帕金森病脑干部位脱色素的体内评估:作为多中心研究严重程度标志物的潜力。
Radiology. 2017 Jun;283(3):789-798. doi: 10.1148/radiol.2016160662. Epub 2016 Nov 7.